Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial JF Howard, V Bril, T Vu, C Karam, S Peric, T Margania, H Murai, ... The Lancet Neurology 20 (7), 526-536, 2021 | 282 | 2021 |
Primary stroke prevention worldwide: translating evidence into action MO Owolabi, AG Thrift, A Mahal, M Ishida, S Martins, WD Johnson, ... The Lancet Public Health 7 (1), e74-e85, 2022 | 266 | 2022 |
Global impact of COVID-19 on stroke care RG Nogueira, M Abdalkader, MM Qureshi, MR Frankel, OY Mansour, ... International journal of stroke 16 (5), 573-584, 2021 | 144 | 2021 |
European Academy of Neurology and European Stroke Organization consensus statement and practical guidance for pre‐hospital management of stroke A Kobayashi, A Czlonkowska, GA Ford, AC Fonseca, GJ Luijckx, J Korv, ... European journal of neurology 25 (3), 425-433, 2018 | 130 | 2018 |
Global impact of COVID-19 on stroke care and IV thrombolysis RG Nogueira, MM Qureshi, M Abdalkader, SO Martins, H Yamagami, ... Neurology 96 (23), e2824-e2838, 2021 | 123 | 2021 |
Stroke with internal carotid artery stenosis A Tsiskaridze, G Devuyst, GR de Freitas, G van Melle, J Bogousslavsky Archives of neurology 58 (4), 605-609, 2001 | 102 | 2001 |
Stroke incidence and 30-day case-fatality in a suburb of Tbilisi: results of the first prospective population-based study in Georgia A Tsiskaridze, M Djibuti, G Van Melle, G Lomidze, S Apridonidze, ... Stroke 35 (11), 2523-2528, 2004 | 95 | 2004 |
Correlation between MMP-9 and extracellular cytokine HMGB1 in prediction of human ischemic stroke outcome N Sapojnikova, T Kartvelishvili, N Asatiani, V Zinkevich, I Kalandadze, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1842 (9 …, 2014 | 67 | 2014 |
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study V Bril, A Drużdż, J Grosskreutz, AA Habib, R Mantegazza, S Sacconi, ... The Lancet Neurology 22 (5), 383-394, 2023 | 65 | 2023 |
Primary brain tumour epidemiology in Georgia: first-year results of a population-based study D Gigineishvili, N Shengelia, G Shalashvili, S Rohrmann, A Tsiskaridze, ... Journal of neuro-oncology 112, 241-246, 2013 | 44 | 2013 |
Pragmatic solutions to reduce the global burden of stroke: a World Stroke Organization–Lancet Neurology Commission VL Feigin, MO Owolabi, F Abd-Allah, RO Akinyemi, NV Bhattacharjee, ... The Lancet Neurology 22 (12), 1160-1206, 2023 | 37 | 2023 |
Management of ischemic stroke in Central and Eastern Europe CEESS Working Group International journal of stroke 10 (SA100), 125-127, 2015 | 31 | 2015 |
Incidence rates of the primary brain tumours in Georgia-a population-based study D Gigineishvili, T Gigineishvili, A Tsiskaridze, R Shakarishvili BMC neurology 14, 1-8, 2014 | 30 | 2014 |
Education and training of European neurologists in dementia SG Hasselbalch, S Baloyannis, M Denislic, B Dubois, W Oertel, M Rossor, ... European journal of neurology 14 (5), 505-509, 2007 | 23 | 2007 |
The 2006 Helsingborg consensus conference on European stroke strategies: summary of conference proceedings and background to the 2nd Helsingborg Declaration B Norrving International Journal of Stroke 2 (2), 139-143, 2007 | 21 | 2007 |
Massive haemorrhagic transformation in cardioembolic stroke: the role of arterial wall trauma and dissection GR De Freitas, A Carruzzo, A Tsiskaridze, JA Lobrinus, J Bogousslavsky Journal of Neurology, Neurosurgery & Psychiatry 70 (5), 672-674, 2001 | 18 | 2001 |
Cognitive correlates of leukoaraiosis in the early stages of Alzheimer's disease. A Tsiskaridze, R Shakarishvili, M Janelidze, T Vashadze, M Chikhladze Functional neurology 13 (1), 17-25, 1998 | 17 | 1998 |
Violent behavior S Sopromadze, A Tsiskaridze Neurologic-Psychiatric Syndromes in Focus-Part II 42, 106-121, 2018 | 14 | 2018 |
Plasma antioxidant activity as a marker for a favourable outcome in acute ischemic stroke N Sapojnikova, N Asatiani, T Kartvelishvili, I Kalandadze, A Tsiskaridze Antioxid. Enzym, 2012 | 14 | 2012 |
Ethical considerations in non-experimental studies: Georgian and Norwegian experience. G Lobzhanidze, N Chikhladze, N Pitskhelauri, A Tsiskaridze | 11 | 2016 |